Bionx prices flotation:
This article was originally published in Clinica
Executive Summary
Bionx Implants has priced its initial public offering at $10.50 a share, below the $13 assumed in the prospectus (see Clinica No 749, p 14). As planned, the developer of implants for orthopaedics, urology, dentistry and maxillo-facial surgery sold two million shares.